MaxLinear (MXL) has had the highest return since March 27, 2026 by a mid-cap US stock, returning 426.9%.
| ASSET | % RETURN |
|---|---|
MaxLinear (MXL) | 426.88% |
Penguin Solutions (PENG) | 354.91% |
Iovance Biotherapeutics (IOVA) | 297.81% |
Abcellera Biologics (ABCL) | 281.72% |
CareDx (CDNA) | 264.01% |
AMC Entertainment (AMC) | 209.28% |
Strive (ASST) | 177.1% |
GRAIL, LLC (GRAL) | 169.35% |
Gitlab (GTLB) | 169.28% |
Xometry (XMTR) | 168.89% |
Clover Health Investments (CLOV) | 167.04% |
Hinge Health (HNGE) | 162.05% |
BlackBerry (BB) | 160% |
Netskope, Inc Class A Common Stock (NTSK) | 148.67% |
Sellas Life Sciences (SLS) | 146.49% |
Pulse Biosciences (PLSE) | 142.82% |
Five9 (FIVN) | 141.34% |
Insight Enterprises (NSIT) | 141.28% |
Kodiak Sciences (KOD) | 136.95% |
Amplitude (AMPL) | 136.38% |
Maravai Lifesciences Holdings (MRVI) | 130.72% |
Okeanis Eco Tankers (ECO) | 130% |
Silicon Motion Technology (SIMO) | 129.06% |
Tenable (TENB) | 128.79% |
Aehr Test Systems (AEHR) | 127.8% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.